Obi Greenman
Chief Executive Officer at CERUS CORPORATION
Net worth: 5 M $ as of 2024-06-29
Obi Greenman active positions
| Companies | Position | Start | End |
|---|---|---|---|
| CERUS CORPORATION | Director/Board Member | 2011-04-20 | - |
| Chief Executive Officer | 2011-04-20 | - | |
| President | 2011-04-20 | - | |
| Corporate Officer/Principal | 1998-12-31 | 2008-07-31 | |
| Sales & Marketing | 2008-07-31 | 2011-04-20 |
Career history of Obi Greenman
Former positions of Obi Greenman
| Companies | Position | Start | End |
|---|---|---|---|
| CHINOOK THERAPEUTICS, INC. | Director/Board Member | 2010-05-31 | 2023-08-10 |
| Independent Dir/Board Member | 2010-05-31 | 2023-08-10 | |
| BAXTER INTERNATIONAL INC. | Corporate Officer/Principal | 1994-12-31 | 1994-12-31 |
| CHINOOK THERAPEUTICS, INC. | Director/Board Member | 2011-06-22 | - |
| Independent Dir/Board Member | 2010-05-31 | - |
Training of Obi Greenman
| Stanford University | Undergraduate Degree |
Statistics
International
| United States | 6 |
Operational
| Director/Board Member | 3 |
| Corporate Officer/Principal | 2 |
| Independent Dir/Board Member | 2 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| CERUS CORPORATION | Health Technology |
| BAXTER INTERNATIONAL INC. | Health Technology |
| Private companies | 2 |
|---|---|
Aduro BioTech, Inc.
 Aduro BioTech, Inc. Pharmaceuticals: MajorHealth Technology Aduro BioTech, Inc. is a clinical-stage immunotherapy company, which engages in the discovery, development, and commercialization of therapies that transform the treatment of diseases, including cancer. Its technology platforms include STING Pathway Activator, B-select monoclonal antibody, and LADD, or Live, Attenuated, Double-Deleted Listeria monocytogenes. The company's platforms stimulate and/or regulate innate and adaptive immune responses, either as single agents or in combination with conventional therapies like chemotherapy and radiation as well as other novel immunotherapies. Aduro BioTech was founded in 2000 and is headquartered in Berkeley, CA. | Health Technology |
Chinook Therapeutics, Inc.
 Chinook Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Chinook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing, and commercializing precision medicines for rare, severe chronic kidney diseases. The company was founded in 2019 and is headquartered in Seattle, WA. | Health Technology |
- Stock Market
- Insiders
- Obi Greenman
- Experience
